Daito Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3486150000
JPY
1,305.00
-2 (-0.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
May'25
May'24
May'23
May'22
May'21
May'20
May'19
Net Sales
50,643.00
46,895.00
45,101.00
43,464.00
48,709.17
44,997.11
41,135.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
50,643.00
46,895.00
45,101.00
43,464.00
48,709.17
44,997.11
41,135.05
Raw Material Cost
42,005.00
37,221.00
34,946.00
32,157.00
38,049.26
35,626.58
32,586.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
123.00
41.00
12.00
9.00
7.85
11.88
20.89
Selling and Distribution Expenses
6,017.00
3,431.00
3,078.00
2,990.00
2,710.93
2,607.26
2,392.02
Other Expenses
-12.30
230.80
185.30
174.00
202.48
138.87
158.79
Total Expenditure (Excl Depreciation)
48,022.00
43,001.00
39,889.00
36,896.00
42,792.85
39,634.40
36,587.04
Operating Profit (PBDIT) excl Other Income
2621
3894
5212
6568
5916.3
5362.7
4548
Other Income
493.00
322.00
-115.00
327.00
156.28
404.34
331.43
Operating Profit (PBDIT)
7,446.00
7,875.00
8,967.00
10,208.00
9,226.93
8,717.54
7,731.97
Interest
123.00
41.00
12.00
9.00
7.85
11.88
20.89
Exceptional Items
-33.00
45.00
-8.00
-166.00
-190.85
-160.03
-239.73
Gross Profit (PBDT)
8,638.00
9,674.00
10,155.00
11,307.00
10,659.91
9,370.53
8,548.83
Depreciation
4,332.00
3,659.00
3,870.00
3,313.00
3,154.33
2,950.48
2,852.53
Profit Before Tax
2,958.00
4,218.00
5,076.00
6,720.00
5,873.91
5,595.15
4,618.81
Tax
1,192.00
1,040.00
1,549.00
2,092.00
1,716.87
1,670.41
1,122.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,908.00
3,294.00
3,599.00
4,667.00
4,246.46
3,944.71
3,513.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,908.00
3,294.00
3,599.00
4,667.00
4,246.46
3,944.71
3,513.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-143.00
-116.00
-72.00
-40.00
-89.42
-19.97
-16.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,765.00
3,178.00
3,527.00
4,627.00
4,157.03
3,924.74
3,496.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,003.00
52,069.00
50,672.00
47,307.00
41,618.96
36,509.21
30,942.04
Earnings per share (EPS)
62.72
105.0
113.72
152.45
141.38
139.75
127.61
Diluted Earnings per share
62.72
105.0
113.72
152.45
141.38
139.75
127.61
Operating Profit Margin (Excl OI)
5.18%
8.3%
11.56%
15.11%
12.15%
11.92%
11.06%
Gross Profit Margin
14.39%
16.8%
19.84%
23.08%
18.53%
18.99%
18.16%
PAT Margin
3.77%
7.02%
7.98%
10.74%
8.72%
8.77%
8.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2025 is 7.99% vs 3.98% in May 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended May 2025 is -44.46% vs -9.90% in May 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2025 is -7.94% vs -16.84% in May 2024

stock-summary

Interest

YoY Growth in year ended May 2025 is 200.00% vs 241.67% in May 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended May 2025 has fallen from May 2024

Compare Annual Results Of Daito Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
50,643.00
0.00
50,643.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
50,643.00
0.00
50,643.00
Raw Material Cost
42,005.00
9.37
41,995.63
448,192.42%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
404.83
-404.83
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
123.00
18.94
104.06
549.42%
Selling and Distribution Expenses
6,017.00
1,148.75
4,868.25
423.79%
Other Expenses
-12.30
193.42
-205.72
-106.36%
Total Expenditure (Excl Depreciation)
48,022.00
3,516.09
44,505.91
1,265.78%
Operating Profit (PBDIT) excl Other Income
2,621.00
-3,516.09
6,137.09
174.54%
Other Income
493.00
515.07
-22.07
-4.28%
Operating Profit (PBDIT)
7,446.00
-2,991.66
10,437.66
348.89%
Interest
123.00
18.94
104.06
549.42%
Exceptional Items
-33.00
9.30
-42.30
-454.84%
Gross Profit (PBDT)
8,638.00
-9.37
8,647.37
92,287.83%
Depreciation
4,332.00
9.37
4,322.63
46,132.66%
Profit Before Tax
2,958.00
-3,010.67
5,968.67
198.25%
Tax
1,192.00
-127.78
1,319.78
1,032.85%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,908.00
-2,882.89
4,790.89
166.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,908.00
-2,882.89
4,790.89
166.18%
Share in Profit of Associates
0
0
0.00
Minority Interest
-143.00
0.00
-143.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,765.00
-2,882.89
4,647.89
161.22%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,003.00
1,762.92
50,240.08
2,849.82%
Earnings per share (EPS)
62.72
-41.86
104.58
249.83%
Diluted Earnings per share
62.72
-41.86
104.58
249.83%
Operating Profit Margin (Excl OI)
5.18%
0.00%
0.00
5.18%
Gross Profit Margin
14.39%
0.00%
0.00
14.39%
PAT Margin
3.77%
0.00%
0.00
3.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,064.30 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 7.99% vs 3.98% in May 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 176.50 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is -44.46% vs -9.90% in May 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 695.30 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is -7.94% vs -16.84% in May 2024

Annual - Interest
Interest 12.30 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 200.00% vs 241.67% in May 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.18%
in May 2025

Figures in %
stock-summary

YoY Growth in year ended May 2025 has fallen from May 2024